Jean-frederic F. Colombel

Gastroenterology
17 E 102nd St
New York, NY 10029

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

Journal: Gut
Published: December 08, 2025

Patients' attitudes to disease prevention in inflammatory bowel disease: a US-based survey.

Patients' attitudes to disease prevention in inflammatory bowel disease: a US-based survey.

Journal: Crohn's & colitis 360
Published: August 27, 2025

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.

Journal: Journal of Crohn's & colitis
Published: June 13, 2025

Author Correction: Gut microbiota strain richness is species specific and affects engraftment.

Author Correction: Gut microbiota strain richness is species specific and affects engraftment.

Journal: Nature
Published: January 28, 2025

Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials.

Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 16, 2024

Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients With Crohn's Disease-Like Pouch Inflammation.

Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients With Crohn's Disease-Like Pouch Inflammation.

Journal: The American journal of gastroenterology
Published: May 10, 2024

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease.

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease.

Journal: Gastroenterology
Published: January 19, 2024

From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health.

From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health.

Journal: Autoimmunity reviews
Published: November 09, 2023

Letter: 'No first among equals'-Authors' reply.

Letter: 'No first among equals'-Authors' reply.

Journal: Alimentary pharmacology & therapeutics
Published: November 07, 2023

Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.

Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 12, 2023

Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).

Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: July 11, 2023

Systematic review: Scores used to predict outcomes in acute severe ulcerative colitis.

Systematic review: Scores used to predict outcomes in acute severe ulcerative colitis.

Journal: Alimentary pharmacology & therapeutics
Published: June 20, 2023
Showing 1-12 of 71

Last Updated: 09/26/2026